Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Salim Syed is an analyst at Mizuho. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 06/25/2024 | WVE | Buy Now | WAVE Life Sciences | $4.99 | 280.76% | $19 → $19 | Reiterates | Outperform → Outperform | Get Alert |
| 05/09/2024 | AMGN | Buy Now | Amgen | $312.45 | -24.79% | $223 → $235 | Maintains | Neutral | Get Alert |
| 04/09/2024 | ELVN | Buy Now | Enliven Therapeutics | $23.37 | 45.49% | → $34 | Initiates | → Buy | Get Alert |
| 03/22/2024 | NKTX | Buy Now | Nkarta | $5.91 | 323.01% | $31 → $25 | Maintains | Buy | Get Alert |
| 03/12/2024 | WVE | Buy Now | WAVE Life Sciences | $4.99 | 280.76% | $10 → $19 | Maintains | Buy | Get Alert |
| 03/12/2024 | PCVX | Buy Now | Vaxcyte | $75.51 | 49.65% | $69 → $113 | Maintains | Buy | Get Alert |
| 03/06/2024 | CYTK | Buy Now | Cytokinetics | $54.18 | 82.72% | $103 → $99 | Maintains | Buy | Get Alert |
| 03/06/2024 | CRSP | Buy Now | CRISPR Therapeutics | $54.14 | 82.86% | $82 → $99 | Maintains | Buy | Get Alert |
| 03/05/2024 | NKTX | Buy Now | Nkarta | $5.91 | 424.53% | $9 → $31 | Maintains | Buy | Get Alert |
| 03/05/2024 | BBIO | Buy Now | BridgeBio Pharma | $25.32 | 109.32% | $60 → $53 | Maintains | Buy | Get Alert |
| 02/22/2024 | GILD | Buy Now | Gilead Sciences | $68.65 | 31.1% | $101 → $90 | Maintains | Buy | Get Alert |
| 02/22/2024 | BIIB | Buy Now | Biogen | $231.82 | 19.49% | $355 → $277 | Maintains | Buy | Get Alert |
| 01/22/2024 | CYTK | Buy Now | Cytokinetics | $54.18 | 90.11% | $80 → $103 | Maintains | Buy | Get Alert |
| 12/08/2023 | CRSP | Buy Now | CRISPR Therapeutics | $54.14 | 51.46% | → $82 | Reiterates | Buy → Buy | Get Alert |
| 12/07/2023 | PCVX | Buy Now | Vaxcyte | $75.51 | -8.62% | → $69 | Initiates | → Buy | Get Alert |
| 11/16/2023 | NKTX | Buy Now | Nkarta | $5.91 | 52.28% | $15 → $9 | Maintains | Buy | Get Alert |
| 11/09/2023 | ATRA | Buy Now | Atara Biotherapeutics | $8.50 | -88.24% | $775 → $25 | Downgrade | Buy → Neutral | Get Alert |
| 09/27/2023 | CRSP | Buy Now | CRISPR Therapeutics | $54.14 | 51.46% | → $82 | Initiates | → Buy | Get Alert |
| 08/28/2023 | BBIO | Buy Now | BridgeBio Pharma | $25.32 | 136.97% | → $60 | Reiterates | Buy → Buy | Get Alert |
| 08/14/2023 | BIIB | Buy Now | Biogen | $231.82 | 44.51% | $340 → $335 | Maintains | Buy | Get Alert |
| 08/14/2023 | NKTX | Buy Now | Nkarta | $5.91 | 153.81% | $26 → $15 | Maintains | Buy | Get Alert |
| 08/14/2023 | BBIO | Buy Now | BridgeBio Pharma | $25.32 | 136.97% | $50 → $60 | Maintains | Buy | Get Alert |
| 08/14/2023 | AMGN | Buy Now | Amgen | $312.45 | -28.63% | $214 → $223 | Maintains | Neutral | Get Alert |
| 05/24/2023 | WVE | Buy Now | WAVE Life Sciences | $4.99 | 100.4% | $13 → $10 | Maintains | Buy | Get Alert |
| 05/08/2023 | BBIO | Buy Now | BridgeBio Pharma | $25.32 | 14.53% | $23 → $29 | Maintains | Buy | Get Alert |
| 04/14/2023 | WVE | Buy Now | WAVE Life Sciences | $4.99 | 160.52% | → $13 | Reiterates | → Buy | Get Alert |
| 03/28/2023 | UBX | Buy Now | Unity Biotechnology | $1.32 | 354.55% | $12 → $6 | Maintains | Buy | Get Alert |
| 02/14/2023 | GILD | Buy Now | Gilead Sciences | $68.65 | 47.12% | $88 → $101 | Maintains | Buy | Get Alert |
| 02/07/2023 | ATRA | Buy Now | Atara Biotherapeutics | $8.50 | 264.71% | → $775 | Reiterates | → Buy | Get Alert |
| 11/16/2022 | UBX | Buy Now | Unity Biotechnology | $1.32 | 809.09% | $80 → $12 | Maintains | Buy | Get Alert |
| 11/16/2022 | NKTX | Buy Now | Nkarta | $5.91 | 339.93% | $81 → $26 | Maintains | Buy | Get Alert |
| 11/16/2022 | CHRS | Buy Now | Coherus BioSciences | $1.73 | 1113.87% | $28 → $21 | Maintains | Buy | Get Alert |
| 11/16/2022 | ASMB | Buy Now | Assembly Biosciences | $14.42 | -79.2% | $168 → $36 | Maintains | Buy | Get Alert |
| 11/08/2022 | GILD | Buy Now | Gilead Sciences | $68.65 | 28.19% | $75 → $88 | Maintains | Buy | Get Alert |
| 11/01/2022 | BIIB | Buy Now | Biogen | $231.82 | 40.19% | $270 → $325 | Maintains | Buy | Get Alert |
| 09/28/2022 | BIIB | Buy Now | Biogen | $231.82 | 16.47% | $207 → $270 | Upgrade | Neutral → Buy | Get Alert |
| 08/24/2022 | BBIO | Buy Now | BridgeBio Pharma | $25.32 | -9.16% | $25 → $23 | Maintains | Buy | Get Alert |
| 08/16/2022 | UBX | Buy Now | Unity Biotechnology | $1.32 | 506.06% | $70 → $80 | Maintains | Buy | Get Alert |
| 08/16/2022 | CHRS | Buy Now | Coherus BioSciences | $1.73 | 1518.5% | $25 → $28 | Maintains | Buy | Get Alert |
| 08/16/2022 | ATRA | Buy Now | Atara Biotherapeutics | $8.50 | 264.71% | $975 → $775 | Maintains | Buy | Get Alert |
| 05/20/2022 | CHRS | Buy Now | Coherus BioSciences | $1.73 | 1345.09% | $30 → $25 | Maintains | Buy | Get Alert |
| 05/16/2022 | CYTK | Buy Now | Cytokinetics | $54.18 | 47.66% | $54 → $80 | Maintains | Buy | Get Alert |
| 05/10/2022 | AMGN | Buy Now | Amgen | $312.45 | -33.43% | $202 → $208 | Maintains | Neutral | Get Alert |
| 02/08/2022 | GILD | Buy Now | Gilead Sciences | $68.65 | 9.25% | $81 → $75 | Maintains | Buy | Get Alert |
| 01/12/2022 | BIIB | Buy Now | Biogen | $231.82 | -10.71% | $270 → $207 | Maintains | Neutral | Get Alert |
| 12/01/2021 | CYTK | Buy Now | Cytokinetics | $54.18 | -0.33% | — | Maintains | Buy | Get Alert |
| 11/22/2021 | AMGN | Buy Now | Amgen | $312.45 | -37.91% | — | Maintains | Neutral | Get Alert |
